csirt@kutim:~/threat-intel/cve/CVE-2023-34035

Katalog CVE

CVSS 5.3 · Medium EPSS 0,66%

Kerentanan Incorrect Authorization pada vmware spring security. Skor CVSS 3.1 5.3 (Medium) menurut NVD.

Deskripsi (NVD)

Spring Security versions 5.8 prior to 5.8.5, 6.0 prior to 6.0.5, and 6.1 prior to 6.1.2 could be susceptible to authorization rule misconfiguration if the application uses requestMatchers(String) and multiple servlets, one of them being Spring MVC’s DispatcherServlet. (DispatcherServlet is a Spring MVC component that maps HTTP endpoints to methods on @Controller-annotated classes.) Specifically, an application is vulnerable when all of the following are true: * Spring MVC is on the classpath * Spring Security is securing more than one servlet in a single application (one of them being Spring MVC’s DispatcherServlet) * The application uses requestMatchers(String) to refer to endpoints that are not Spring MVC endpoints An application is not vulnerable if any of the following is true: * The application does not have Spring MVC on the classpath * The application secures no servlets other than Spring MVC’s DispatcherServlet * The application uses requestMatchers(String) only for Spring MVC endpoints

Rincian

Terbit di NVD
18 Juli 2023
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
5.3 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-863: Incorrect Authorization
EPSS (30 hari)
0,66% peluang dieksploitasi; lebih tinggi dari 50,1% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
vmware spring security Versi 5.8.0 hingga sebelum 5.8.5
vmware spring security Versi 6.0.0 hingga sebelum 6.0.5
vmware spring security Versi 6.1.0 hingga sebelum 6.1.2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.